Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Full Paper
  • Published:

Functional promoter haplotypes of the human FAS gene are associated with the phenotype of SLE characterized by thrombocytopenia

Genes & Immunity volume 6, pages 699–706 (2005)Cite this article

Abstract

Systemic lupus erythematosus (SLE) is an autoimmune disorder characterized by production of autoantibodies against intracellular antigens and tissue injury. Defective apoptosis of activated immune cells leads to the development of autoantibodies in SLE. FasL initiated apoptosis is central for peripheral tolerance. Fas deficiencies in humans and mice predispose toward systemic autoimmunity. SLE is conferred by many genes. The genetic effects may be concentrated by familial clustering or by stratifying of subphenotypes. We have tested polymorphisms and haplotypes in FAS and FASL for association to SLE or subphenotypes in 126 multiplex American SLE pedigrees and found association of the FAS codon214 ACC/T as well as the FAS−670G>A′-codon214 ACC/T′ haplotype to thrombocytopenia in SLE. Furthermore we have functionally characterized the FAS/FASL promoter polymorphisms associated with SLE in other populations and demonstrate that the activity depends on the allelic variants as well as on the haplotype. The presence of FAS−670G, which affects STAT1 binding, leads to the highest activity. FASL−844C activity is modified by the cis acting −478A and, hence, the haplotype and not the individual variant, determines the promoter activity. We conclude that the FAS/FASL promoter haplotypes are functional and that polymorphisms in FAS may contribute to thrombocytopenia in SLE.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Harley JB, Moser KL, Gaffney PM, Behrens TW . The genetics of human systemic lupus erythematosus. Curr Opin Immunol 1998; 10: 690–696.

    Article  CAS  PubMed  Google Scholar 

  2. Deapen D, Escalante A, Weinrib L et al. A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum 1992; 35: 311–318.

    Article  CAS  PubMed  Google Scholar 

  3. Kelly JA, Moser KL, Harley JB . The genetics of systemic lupus erythematosus: putting the pieces together. Genes Immun 2002; 3 (Suppl 1): S71–S85.

    Article  CAS  PubMed  Google Scholar 

  4. Salmon JE, Millard S, Schachter LA et al. Fc gamma RIIA alleles are heritable risk factors for lupus nephritis in African Americans. J Clin Invest 1996; 97: 1348–1354.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Arnett FC . The genetics of human lupus. In: Wallace DJ, Hahn BH (eds). Dubois' Lupus Erythematosus. Williams & Wilkins: Baltimore, 1997, pp 77–117.

    Google Scholar 

  6. Moser KL, Neas BR, Salmon JE et al. Genome scan of human systemic lupus erythematosus: evidence for linkage on chromosome 1q in African-American pedigrees. Proc Natl Acad Sci USA 1998; 95: 14869–14874.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Gaffney PM, Kearns GM, Shark KB et al. A genome-wide search for susceptibility genes in human systemic lupus erythematosus sib-pair families. Proc Natl Acad Sci USA 1998; 95: 14875–14879.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Lindqvist AKB, Steinsson K, Johanneson B et al. A susceptibility locus for human systemic lupus erythematosus (hSLE1) on chromosome 2q. J Autoimmun 2000; 14: 169–178.

    Article  CAS  PubMed  Google Scholar 

  9. Gaffney PM, Ortmann WA, Selby SA et al. Genome screening in human systemic lupus erythematosus: results from a second Minnesota cohort and combined analyses of 187 sib-pair families. Am J Hum Genet 2000; 66: 547–556.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Shai R, Quismorio FP, Li L et al. Genome-wide screen for systemic lupus erythematosus susceptibility genes in multiplex families. Hum Mol Genet 1999; 8: 639–644.

    Article  CAS  PubMed  Google Scholar 

  11. Gray-Mcguire C, Moser KL, Gaffney PM et al. Genome scan of human systemic lupus erythematosus by regression modeling: evidence of linkage and epistasis at 4p16–15.2. Am J Hum Genet 2000; 67: 1460–1469.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Koskenmies S, Lahermo P, Julkunen H, Ollikainen V, Kere J, Widen E . Linkage mapping of systemic lupus erythematosus (SLE) in Finnish families multiply affected by SLE. J Med Genet 2004; 41: e2–e5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Tsao BP, Grossman JA, Riemekasten G et al. Familiality and co-occurrence of clinical features of systemic lupus erythematosus. Arthritis Rheum 2002; 46: 2678–2685.

    Article  PubMed  Google Scholar 

  14. Rao S, Olson JM, Moser KL et al. Linkage analysis of human systemic lupus erythematosus-related traits: a principal component approach. Arthritis Rheum 2001; 44: 2807–2818.

    Article  CAS  PubMed  Google Scholar 

  15. Olson JM, Song Y, Dudek DM et al. A genome screen of systemic lupus erythematosus using affected-relative-pair linkage analysis with covariates demonstrates genetic heterogeneity. Genes Immun 2002; 3 (Suppl 1): S5–S12.

    Article  CAS  PubMed  Google Scholar 

  16. Drenkard C, Villa AR, Alarcon-Segovia D, Perez-Vazquez ME . Influence of the antiphospholipid syndrome in the survival of patients with systemic lupus erythematosus. J Rheumatol 1994; 21: 1067–1072.

    CAS  PubMed  Google Scholar 

  17. Mok CC, Lee KW, Ho CT, Lau CS, Wong RW . A prospective study of survival and prognostic indicators of systemic lupus erythematosus in a southern Chinese population. Rheumatology (Oxford) 2000; 39: 399–406.

    Article  CAS  Google Scholar 

  18. Reveille JD, Bartolucci A, Alarcon GS . Prognosis in systemic lupus erythematosus. Negative impact of increasing age at onset, black race, and thrombocytopenia, as well as causes of death. Arthritis Rheum 1990; 33: 37–48.

    Article  CAS  PubMed  Google Scholar 

  19. Ward MM, Pyun E, Studenski S . Mortality risks associated with specific clinical manifestations of systemic lupus erythematosus. Arch Intern Med 1996; 156: 1337–1344.

    Article  CAS  PubMed  Google Scholar 

  20. Scofield RH, Bruner GR, Kelly JA et al. Thrombocytopenia identifies a severe familial phenotype of systemic lupus erythematosus and reveals genetic linkages at 1q22 and 11p13. Blood 2003; 101: 992.

    Article  CAS  PubMed  Google Scholar 

  21. Adachi M, Watanabe-Fukunaga R, Nagata S . Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice. Proc Natl Acad Sci USA 1993; 90: 1756–1760.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S . Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992; 356: 314–317.

    Article  CAS  PubMed  Google Scholar 

  23. Takahashi T, Tanaka M, Brannan CI et al. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 1994; 76: 969–976.

    Article  CAS  PubMed  Google Scholar 

  24. Nagata S, Golstein P . The Fas death factor. Science 1995; 267: 1449–1456.

    Article  CAS  PubMed  Google Scholar 

  25. Giese T, Davidson WF . Chronic treatment of C3H-lpr/lpr and C3H-gld/gld mice with anti-CD8 monoclonal antibody prevents the accumulation of double negative T cells but not autoantibody production. J immunol 1994; 152: 2000.

    CAS  PubMed  Google Scholar 

  26. Budihardjo I, Oliver H, Lutter M, Luo X, Wang X . Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol 1999; 15: 269–290.

    Article  CAS  PubMed  Google Scholar 

  27. Cohen GM . Caspases: the executioners of apoptosis. Biochem J 1997; 326 (Part 1): 1–16.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Fukuyama H, Adachi M, Suematsu S et al. Requirement of Fas expression in B cells for tolerance induction. Eur J Immunol 2002; 32: 223–230.

    Article  CAS  PubMed  Google Scholar 

  29. Inaba M, Kurasawa K, Mamura M, Kumano K, Saito Y, Iwamoto I . Primed T cells are more resistant to Fas-mediated activation- induced cell death than naive T cells. J Immunol 1999; 163: 1315–1320.

    CAS  PubMed  Google Scholar 

  30. Nolsoe RL, Kristiansen OP, Sangthongpitag K et al. Complete molecular scanning of the human Fas gene: mutational analysis and linkage studies in families with type I diabetes mellitus. The Danish Study Group of Diabetes in Childhood and The Danish IDDM Epidemiology and Genetics Group. Diabetologia 2000; 43: 800.

    Article  CAS  PubMed  Google Scholar 

  31. Nolsoe RL, Kristiansen OP, Larsen ZM, Johannesen J, Pociot F, Mandrup-Poulsen T . Complete mutation scan of the human Fas ligand gene: linkage studies in Type I diabetes mellitus families. Diabetologia 2002; 45: 134.

    Article  CAS  PubMed  Google Scholar 

  32. Sunden SL, Alward WL, Nichols BE et al. Fine mapping of the autosomal dominant juvenile open angle glaucoma (GLC1A) region and evaluation of candidate genes. Genome Res 1996; 6: 862.

    Article  CAS  PubMed  Google Scholar 

  33. Reichlin M, Mattioli M . Correlation of a precipitin reaction to an RNAprotein antigen and a low prevalence of nephritis in patients with systemic lupus erythematosus. N Engl J Med 1972; 286: 908.

    Article  CAS  PubMed  Google Scholar 

  34. Kanemitsu S, Ihara K, Saifddin A et al. A functional polymorphism in Fas (CD95/APO-1) gene promoter associated with systemic lupus erythematosus. J Rheumatol 2002; 29: 1183–1188.

    CAS  PubMed  Google Scholar 

  35. Rudert F, Lindridge E, Lasham A, Wang Y, Grandison P, Watson J . Silencer and enhancer regions in the human CD95 (Fas/APO-1) gene with sequence similarity to the granulocyte–macrophage colony-stimulating factor promoter: binding of single strand-specific silencer factors and AP-1 and NF-AT-like enhancer factors. DNA Cell Biol 1998; 17: 991.

    Article  CAS  PubMed  Google Scholar 

  36. Lee YH, Kim YR, Ji JD, Sohn J, Song GG . Fas promoter −670 polymorphism is associated with development of anti-RNP antibodies in systemic lupus erythematosus. J Rheumatol 2001; 28: 2008–2011.

    CAS  PubMed  Google Scholar 

  37. Huang QR, Danis V, Lassere M, Edmonds J, Manolios N . Evaluation of a new Apo-1/Fas promoter polymorphism in rheumatoid arthritis and systemic lupus erythematosus patients. Rheumatol 1999; 38: 645–651.

    Article  CAS  Google Scholar 

  38. Wu J, Metz C, Xu X et al. A novel polymorphic CAAT/enhancer-binding protein beta element in the FasL gene promoter alters Fas ligand expression: a candidate background gene in African American systemic lupus erythematosus patients. J Immunol 2003; 170: 132–138.

    Article  CAS  PubMed  Google Scholar 

  39. Cartegni L, Chew SL, Krainer AR . Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet 2002; 3: 285–298.

    Article  CAS  PubMed  Google Scholar 

  40. Rust S, Funke H, Assmann G . Mutagenically separated PCR (MS-PCR): a highly specific one step procedure for easy mutation detection. Nucleic Acids Res 1993; 21: 3623–3629.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Spielman RS, McGinnis RE, Ewens WJ . Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993; 52: 506–516.

    CAS  PubMed  PubMed Central  Google Scholar 

  42. Martin ER, Monks SA, Warren LL, Kaplan NL . A test for linkage and association in general pedigrees: the Pedigree Disequilibrium Test. Am J Hum Genet 2000; 67: 146–154.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Kong A, Cox NJ . Allele-sharing models: LOD scores and accurate linkage tests. Am J Hum Genet 1997; 61: 1179–1188.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Kaplan NL, Hill WG, Weir BS . Likelihood methods for locating disease genes in nonequilibrium populations. Am J Hum Genet 1995; 56: 18–32.

    CAS  PubMed  PubMed Central  Google Scholar 

  45. Lewontin RC . On measures of gametic disequilibrium. Genetics 1988; 120: 849–852.

    CAS  PubMed  PubMed Central  Google Scholar 

  46. Holtz-Heppelmann CJ, Algeciras A, Badley AD, Paya CV . Transcriptional regulation of the human FasL promoter-enhancer region. J Biol Chem 1998; 273: 4416.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Marja Deckert for expert technical assistance.

Author information

Author notes

  1. R L Nolsøe and J A Kelly: These authors contributed equally to the study

Authors and Affiliations

  1. Steno Diabetes Center, Gentofte, Denmark

    R L Nolsøe, F Pociot, O P Kristiansen & T Mandrup-Poulsen

  2. Oklahoma Medical Research Foundation, Oklahoma City, OK, USA

    J A Kelly & J B Harley

  3. Department of Medicine, University of Minnesota School of Medicine, SE Minneapolis, MN, USA

    K L Moser

  4. Department of Molecular Medicine, The Rolf Luft Center for Diabetes Research, Karolinska Institute, Stockholm, Sweden

    T Mandrup-Poulsen

Authors
  1. R L Nolsøe
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J A Kelly
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. F Pociot
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. K L Moser
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. O P Kristiansen
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. T Mandrup-Poulsen
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. J B Harley
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to T Mandrup-Poulsen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nolsøe, R., Kelly, J., Pociot, F. et al. Functional promoter haplotypes of the human FAS gene are associated with the phenotype of SLE characterized by thrombocytopenia. Genes Immun 6, 699–706 (2005). https://doi.org/10.1038/sj.gene.6364259

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gene.6364259

Keywords

This article is cited by

Search

Advanced search

Quick links